The World of Health & Medicine News

HPV infection linked to higher heart risk

HPV infection linked to higher heart risk

Human papillomavirus, along with causing several types of cancer, appears to significantly increase the risk of heart disease, according to research being presented at the American College of Cardiology Scientific Session, opens new tab in Chicago this week.

Pooling data from seven studies that tracked nearly 250,000 volunteers for up to 17 years, researchers found that HPV-positive patients had a 40% higher likelihood of developing cardiovascular disease and twice the risk of developing coronary artery disease in particular, compared with HPV-negative patients.

Even after accounting for sociodemographic factors, medical history, lifestyle behaviors, family history of heart disease and use of blood pressure-lowering drugs, HPV-positive patients still had a 33% higher risk of developing cardiovascular disease.

The researchers say doctors could consider closer heart monitoring for people who test positive for HPV, in keeping with recommendations for patients with other known heart disease risk factors.

“We always talk about cardiovascular risk factors like smoking, high blood pressure and so on, but we know that about 20% of cardiovascular disease cannot be explained by these conventional risk factors,” study leader Dr. Stephen Akinfenwa of UConn School of Medicine in Farmington, Connecticut, said in a statement. “This makes it important to identify non-conventional risk factors like HPV that could potentially be targeted.”

The reason for the association is not clear, but it’s likely related to chronic inflammation, he said.

“We would ultimately like to see if reducing HPV via vaccination could reduce cardiovascular risk.”

spot_img

Explore more

spot_img

Trump health policy uncertainty sends biotech sector into deeper slump

Trump health policy uncertainty sends biotech sector into deeper slump Trump administration cuts across federal health agencies have sent shivers through a biotech industry already...

Novo Nordisk warns consumers about counterfeit versions of Ozempic in US

Novo Nordisk warns consumers about counterfeit versions of Ozempic in US Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug...

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab)...

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma Bristol Myers Squibb (NYSE: BMY)...

DHL delivers the world’s first mobile heart clinic to Burundi

DHL delivers the world's first mobile heart clinic to Burundi - DHL Global Forwarding has successfully transported the world’s first mobile heart clinic for children...

WHO members close to accord on tackling future pandemics, sources say

WHO members close to accord on tackling future pandemics, sources say Members of the World Health Organization are close to a deal on a treaty...

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes Five scientists who contributed to the development of the blockbuster weight-loss drugs Ozempic and Wegovy have picked up...

Kennedy sets September deadline to identify cause of rising US autism...

Kennedy sets September deadline to identify cause of rising US autism rates The United States will identify the cause of autism by September, Secretary of...

Rhythm Pharma’s drug for rare obesity meets late-stage trial goal

Rhythm Pharma's drug for rare obesity meets late-stage trial goal Rhythm Pharmaceuticals (RYTM.O), opens new tab said on Monday its drug Imcivree notably reduced weight in patients...